BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4197873)

  • 1. Alprenolol alone and in conjunction with pentanitrol in angina pectoris. A double-blind study with exercise tests.
    Hansen PF; Rasmussen PA; Nyberg G
    Acta Med Scand; 1973 May; 193(5):419-24. PubMed ID: 4197873
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of alprenolol on hemodynamics in angina pectoris.
    Cullhed I
    Acta Med Scand; 1973 May; 193(5):411-8. PubMed ID: 4717322
    [No Abstract]   [Full Text] [Related]  

  • 3. Prophylactic treatment of angina pectoris. A double-blind cross-over comparison of alprenolol and pentanitrol.
    Aubert A; Nyberg G; Slaastad R; Tjeldflaat L
    Br Med J; 1970 Jan; 1(5690):203-6. PubMed ID: 4391702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison between alprenolol in tablet form (Aptin) and in "sustained release" form (Aptin Durules) in angina pectoris].
    Lorentzen F; Jorgensen P; Nielsen E; Nyberg G; Hvidt S
    Ugeskr Laeger; 1973 Jul; 135(27):1431-8. PubMed ID: 4585750
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of five different long-acting nitroglycerine derivatives on angina pectoris].
    Kaltenbach M; Tiedemann I; Schellhorn W
    Dtsch Med Wochenschr; 1972 Oct; 97(40):1479-84. PubMed ID: 4627249
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of two adrenergic beta-receptor blocking agents, alprenolol and propranolol, in treatment of angina pectoris.
    Heterington DJ; Comerford MB; Nyberg G; Besterman EM
    Br Heart J; 1973 Mar; 35(3):320-33. PubMed ID: 4632566
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of cedilanid-D and alprenolol in angina pectoris.
    Ekelund LG; Johnsson G; Melcher A; Orö L
    Eur J Clin Pharmacol; 1973 Aug; 6(2):113-8. PubMed ID: 4769694
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of the therapeutic efficacy of 4 different delayed-action nitro-derivatives on S-T changes after exercise tests].
    Roncarolo PL; Falcone M; Gabasio C; Aletto C; Guasone V; Allegri M; Giordano MP
    Minerva Cardioangiol; 1978 Sep; 26(9):615-8. PubMed ID: 100745
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of alprenolol on central hemodynamics and exercise tolerance in patients with angina pectoris.
    Jonsson B; Olsson AG; Orö L
    Cardiology; 1973; 58(3):152-61. PubMed ID: 4149331
    [No Abstract]   [Full Text] [Related]  

  • 10. Perhexilene maleate in treatment of angina pectoris.
    Lyon LJ; Nevins MA; Risch S; Henry S
    Lancet; 1971 Jun; 1(7712):1272-4. PubMed ID: 4104721
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemodynamic changes at rest and during exercise in long-term beta-blocker therapy of essential hypertension.
    Lund-Johansen P
    Acta Med Scand; 1974; 195(1-2):117-21. PubMed ID: 4817079
    [No Abstract]   [Full Text] [Related]  

  • 12. Prindolol (Visken) and alprenolol (Aptin) in angina pectoris: a comparative clinical study with special reference to ergometer working capacity tests.
    Bjerle P; Jacobsson KA
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):101-16. PubMed ID: 4218804
    [No Abstract]   [Full Text] [Related]  

  • 13. Exercise tolerance in patients with angina pectoris: daily variation and effect of pentaerythritol tetranitrate.
    Dagenais GR; Mason RE; Friesinger GC; Wender C; Ross RS
    Johns Hopkins Med J; 1969 Dec; 125(6):301-11. PubMed ID: 4905736
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of beta-adrenergic blockade with alprenolol on ST-segment depression and circulatory dynamics during exercise in patients with effort angina.
    Bailey IK; Anderson SD; Rozea PJ; Bernstein L; Nyberg G; Korner PI
    Am Heart J; 1976 Oct; 92(4):416-26. PubMed ID: 961582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of propranolol and alprenolol in angina pectoris--a double blind study].
    Sakakibara H; Matsutani K; Mochizuki S; Kitabatake S; Takagishi S
    Jpn Circ J; 1970 Apr; 34(4):319-33. PubMed ID: 4996004
    [No Abstract]   [Full Text] [Related]  

  • 16. Antianginal effects of pentaerythritol tetranitrate.
    Arce-Gomez E; Aspe y Rosas J; Alcocer Diaz Barreiro L; Diaz Barreiro AL
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2487-91. PubMed ID: 6775303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alprenolol in angina pectoris. A comparative study of the tablet form and slow-release formulation.
    Lorentzen F; Jorgensen P; Nielsen E; Nyberg G; Hvidt S
    Med J Aust; 1975 Oct; 2(17):668-73. PubMed ID: 1107769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinico-functional characteristics of stenocardia and the effectiveness of its treatment with nitrong and erinit].
    Volkov VS; Bratoliubov VP
    Ter Arkh; 1986; 58(5):124-7. PubMed ID: 3090730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting nitrates in the treatment of angina pectoris.
    Reichek N
    JAMA; 1976 Sep; 236(12):1399-402. PubMed ID: 822177
    [No Abstract]   [Full Text] [Related]  

  • 20. The therapeutic role of coronary vasodilators: glyceryl trinitrate, isosorbide dinitrate, and pentaerythritol tetranitrate.
    Russek HI
    Am J Med Sci; 1966 Jul; 252(1):9-20. PubMed ID: 4957459
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.